The first thing a man searches after his doctor mentions finasteride is the side effects. The first thing he finds is a forum thread. Forums select for the men who had problems. They are not a base rate.
This piece is the version a clinician would give you: the trial numbers, the dose-response, the difference between topical and oral, and how we actually think about who should and should not take this drug.
What is finasteride?
Finasteride is an oral 5-alpha reductase (5AR) type II inhibitor. It blocks the enzyme that converts testosterone to dihydrotestosterone (DHT). Lowering DHT lowers the signal at scalp follicles that drives androgenetic alopecia.
At the 1 mg dose used for hair loss, finasteride reduces scalp DHT by about 60 to 70%. The 5 mg dose used for benign prostatic hyperplasia produces a larger reduction. The side-effect profile is dose-related.
The fuller mechanism and comparison to alternatives is in finasteride vs dutasteride vs minoxidil.
Side effects of finasteride: the trial data
In randomized, placebo-controlled trials of finasteride 1 mg daily for androgenetic alopecia, the reported rates were:
| Side effect | Finasteride 1 mg | Placebo |
|---|---|---|
| Decreased libido | 1.8% | 1.3% |
| Erectile dysfunction | 1.3% | 0.7% |
| Decreased ejaculate volume | 1.2% | 0.7% |
| Gynecomastia | <1% | <1% |
| Depression / mood change | <1% | <1% |
The absolute increase over placebo is small but real. The signal is strongest for sexual side effects, present at lower rates for mood, and present at very low rates for breast tissue changes.
These rates are from trials of 1 to 2 years. Longer-term follow-up has not changed the picture dramatically, though the post-marketing literature includes reports of persistent symptoms after discontinuation. We cover that contested territory in post-finasteride syndrome.
How do sexual side effects on finasteride present?
The most common pattern is a subtle decrease in libido that the man notices over weeks. Erectile function is usually less affected than libido. Ejaculate volume often decreases modestly without other changes.
Two practical points:
Onset is gradual. Most on-drug sexual side effects develop over the first 1 to 3 months, not on day one. A man who feels a libido shift at week 6 is in a typical pattern.
Reversal is usually fast. Finasteride has a short half-life (6 to 8 hours). Most on-drug sexual side effects resolve within 4 to 12 weeks of stopping. A meaningful minority of men report symptoms persisting beyond that window. The interpretation of those reports is what makes the PFS conversation contested.
How does topical finasteride compare?
Topical finasteride (typically 0.25% solution applied to the scalp daily) produces meaningful local DHT suppression with substantially lower serum DHT changes than the oral 1 mg dose.
Head-to-head trials of topical versus oral finasteride show similar efficacy at the scalp and lower systemic side-effect rates with the topical formulation. The data is not as deep as for the oral form, but the mechanism predicts what the trials are showing.
For men who want the benefit with a smaller systemic footprint, topical finasteride is a reasonable starting point. It is also a reasonable de-escalation strategy for men who develop side effects on the oral dose but want to continue treatment in some form.
Other side effects to know about
Gynecomastia. Rare (under 1% in trials). Reversible in most cases on cessation. Mechanism is the shift in testosterone-to-estrogen ratio that occurs when DHT is suppressed. Worth checking for at baseline if there is a personal or family history.
Mood changes. Reported in trials and post-marketing at low rates. The relationship between finasteride and depression is debated. Men with a history of depression should discuss baseline mood and have a follow-up plan before starting.
Decreased PSA. Finasteride lowers PSA by about 50%. This is mechanistic, not pathologic, but it matters for prostate cancer screening interpretation. If you are over 50 and on finasteride, your PSA value should be doubled when interpreted against population norms.
Male breast cancer. Extremely rare in absolute terms. A small relative increase has been suggested in post-marketing data. The absolute risk remains very low.
How does the 1 mg hair dose compare to the 5 mg BPH dose?
The 5 mg dose used for benign prostatic hyperplasia produces a larger DHT reduction and a higher rate of all side effects, particularly sexual ones. The men in those trials were also older and had higher baseline rates of sexual dysfunction, so the population is different.
For hair loss, we do not exceed 1 mg daily. There is no demonstrated benefit to higher doses for androgenetic alopecia, and the side-effect curve gets steeper.
What to do if you feel side effects
The practical playbook:
- Confirm timing. Did the symptom start within weeks of beginning the drug? Has anything else changed (sleep, stress, alcohol, a new medication)?
- Check the dose. If you are on 1.25 mg from a compounded source or 2.5 mg from an old prescription, consider dropping to 1 mg.
- Consider a topical switch. Many men tolerate topical finasteride when the oral form caused symptoms.
- Try a structured pause. A 4 to 8 week pause clarifies whether the drug is the driver. If symptoms resolve and recur on rechallenge, the answer is the drug.
- Stop if persistent. If symptoms continue and the trade is no longer acceptable, stop. The hair you have built will recede toward your genetic trajectory over 6 to 12 months. That is a legitimate decision.
How long do side effects last?
For men who experience side effects on the drug:
- Most resolve within 4 to 12 weeks of cessation. Pharmacokinetic washout is fast.
- A minority report symptoms beyond 3 to 6 months. This is the territory of the PFS conversation. The mechanism is unclear, and the rate is contested.
- On-drug resolution. Some men's side effects resolve while continuing the drug, particularly after the first 6 months. The reasons are not fully understood.
Who should not take finasteride?
We do not prescribe finasteride for:
- Men with active or recent prostate cancer (the drug suppresses PSA and complicates surveillance).
- Men with significant baseline sexual dysfunction without first addressing the upstream cause.
- Men with a history of severe depression without a coordinated mental-health plan.
- Men who are trying to conceive and are anxious about any theoretical effect on sperm (the data on this is reassuring, but if the anxiety itself is the issue, that is a real consideration).
Where Vane lands
The side-effect profile of finasteride is real but small in absolute terms. Most men do not develop persistent issues. Some do, and we take their reports seriously.
The clinician's job is to lay out the rates honestly, identify the men for whom the upside is high and the downside is manageable, and have a plan if symptoms emerge. The decision to start is yours. The decision to keep going if something feels off is also yours, and we will support both.
If you have any uncertainty going in, the panel and consultation are the right place to start, not the prescription.
